• Go to navigation
  • Go to content
AstraZeneca International - A global pharmaceutical company

Astrazeneca Worldwide

  • AstraZeneca Websites

Main navigation

  • Home
  • About us
  • Medicines
  • Research
  • Careers
  • Responsibility
  • Partnering
  • Media
    • Corporate reports
    • Facts, products, pipeline
    • Events calendar
    • Media contacts
    • Press releases
    • Photo library
      • Board and management
      • Locations
      • Emerging Markets
      • Logo
      • Operations and Manufacturing
      • Products
      • Research & Development
      • MedImmune Vaccine Production
    • Broadcast Centre
  • Investors

You are here

  • Home
  • Media
  • Photo library
  • Logo

  • Logo's

AstraZeneca Logo 1

AstraZeneca Logo 1

  • Hi-res JPEG

Logo's

  • ???media.now_playing???
    AstraZeneca Logo 1
  • AstraZeneca Logo 2
  • AstraZeneca Logo 3

Not signed in

Please log in or register to access the site.



  • Register
  • Forgotten password?

Page tools

  • Print
  • Bookmark this page

Share price

London
0.00 26.95 GBP
New York
0.00 44.82 USD
Stockholm
0.00 310.10 SEK

At 21-Nov-2009 10:30  GMT

Detailed share price

Introduction to AstraZeneca

Our responsibility

We continue to communicate openly on a range of issues, including:

  • Patient safety
  • Research ethics
  • Sales and marketing
  • Access to medicines
  • Animal research
  • Climate change
  • Pharmaceuticals in the environment

Contact us

  • Contact Press Office
  • Other enquires

Stay in touch

 Subscribe via RSS

 Email alerts

Legal notices

  • Legal notice
  • Privacy policy
  • Sitemap
  • © AstraZeneca 2009

This website is intended for people seeking information on the AstraZeneca International business.  If you are in the US you should visit AstraZeneca US. 

We also have national business sites which can be found under our list of AstraZeneca websites.

We also have specific national and international websites designed for patients and healthcare professionals. If you have a question you can contact us.